Objective

Amid rapid growth—including a Series D funding round, a SPAC merger, and becoming a publicly traded company on NASDAQ—SomaLogic needed to strengthen its brand. The goal was to unify internal teams, establish clarity and consistency, and position the company as the category leader in proteomics.

Approach

We led a comprehensive discovery process, conducting in-depth interviews with stakeholders across the C-suite, product, sales, and marketing. Insights from these sessions revealed gaps between market perception and brand positioning. A full brand audit informed the development of:

• A refreshed message architecture reflecting SomaLogic’s evolved mission.

• A redesigned visual system including updated color palette, typography, iconography, and imagery.

• A curated image and icon library aligned with brand tone and scientific precision.

• Comprehensive brand guidelines for consistency across channels.

The new brand was introduced internally through a company-wide workshop to foster alignment and externally through coordinated digital, owned, and social channels.

Results

• Positioned SomaLogic as a recognized category leader in proteomics.

• Unified internal teams and messaging across business units.

• Strengthened investor and customer communications during and after IPO.

• Earned industry recognition with the Manny Award for Best Corporate Branding by Med Ad News.